FORM 8-K

Company

Compass Therapeutics, Inc.

Filed

April 25, 2024

Period of Report

April 25, 2024

Accession Number

0001171843-24-002220

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →